TARCC, AHA Grants to Aide TTUHSC Researcher
Vijayan to study VDAC1 and mitophagy in Alzheimer’s disease

The grant will support Vijayan’s research into how VDAC1 regulates mitophagy, a critical cellular process that helps maintain healthy mitochondria by removing dysfunctional mitochondria during periods of metabolic stress.
Mitochondrial dysfunction plays a significant role in the development of Alzheimer’s disease. By studying VDAC1, Vijayan aims to uncover novel mechanisms that contribute to this dysfunction, potentially leading to new therapeutic targets. The research will involve both in vitro and in vivo models to examine how disruptions in VDAC1 function may impair mitochondrial clearance and exacerbate neurodegeneration.

“These two grants provide a unique opportunity to investigate the intersection of mitochondrial dysfunction in Alzheimer’s disease and develop innovative strategies to protect neurons and slow disease progression,” Vijayan added. “We are hopeful that our research will lead to meaningful advances in understanding and treating Alzheimer’s disease.”
Related Stories
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
TTUHSC Researchers Seek Novel Therapies for Chronic Pain
The National Institute of Neurological Disorders and Stroke at the NIH recently awarded a $1.94 million grant to Mahmoud Salama Ahmed, Ph.D., and his project team from the Department of Pharmaceutical Sciences at TTUHSC. Jerry H. Hodge School of Pharmacy.
Recent Stories
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.